Global Safety Program Lead - Cell Therapy Oncology & Onco-Hematology

AstraZenecaGaithersburg, MD
$288,059 - $432,089Hybrid

About The Position

AstraZeneca is seeking a Global Safety Program Lead for Cell Therapy Oncology & Onco-Hematology. This role involves providing medico-scientific and clinical strategic leadership within Global Patient Safety, focusing on shaping the safety strategy of high-impact assets and leading cross-functional teams to optimize benefit-risk. The position offers the opportunity to work with a broad cell therapy pipeline, advancing novel Cell and Gene Therapy (CGT) technologies. The role emphasizes in-person collaboration to foster innovation and teamwork, with a minimum of three days per week in the office, balanced with individual flexibility.

Requirements

  • Medical degree or equivalent degree in biomedicine or science, with extensive clinical safety/pharmacovigilance experience.
  • Strong relevant experience in clinical safety or clinical development across pharma/biotech/CRO/academia/Health Authorities, spanning pre‑ and post‑launch.
  • Proven track record of leading asset safety strategy and delivery, with demonstrated strategic influence on clinical studies/programs and benefit–risk decisions.
  • Deep knowledge of global PV regulations, standards, and safety deliverables (e.g., RMPs, PSURs/PSRs), and experience contributing to global regulatory submissions and interactions with major agencies.
  • Strong matrix leadership and influencing skills with cross‑functional leaders (e.g., Clinical Development, Medical Affairs, Regulatory Affairs), including representation at senior governance.
  • Demonstrated people leadership: ability to lead, coach, and mentor safety physicians/scientists; excellent communication skills with the ability to present complex topics to senior leaders.
  • Strong experience and knowledge of Gene & Cell therapy
  • Ability to travel domestically and internationally, as business needs require.

Nice To Haves

  • PhD or other advanced degree in a relevant scientific discipline.
  • Research experience in the GCT field.
  • Medical specialty, or documented training, in oncology and/or haemato-oncology.
  • Basic and/or Translational Research background, including authoring peer reviewed publications.
  • Good knowledge of PV regulations in China, Australia, Japan, rest of Asia.
  • Recognized subject‑matter expertise and sound independent judgment in clinical safety; disease area safety leadership experience.
  • Experience speaking at industry conferences and shaping external safety messaging.
  • Experience supporting in‑licensing/due diligence from a safety perspective.
  • Proven ability to embed new processes/systems and drive continuous improvement in safety ways of working.

Responsibilities

  • Lead the Safety Strategy & Management Team (SSaMT) and Safety Surveillance Team for assigned asset(s), setting safety goals aligned to therapeutic area and product strategy, and ensuring high-quality, compliant delivery of safety activities.
  • Own the scientific and clinical safety content for the asset(s), including safety TPP, safety Go/No‑Go criteria, toxicity management guidelines, and safety messaging, integrating inputs from clinical, epidemiology, pre‑clinical, and literature.
  • Represent Global Patient Safety at key governance and external forums (e.g., DRC, eCRC, SARB, FSIRB, DSMB/DMC, MARC, CPT, GPT, Advisory Boards) in partnership with the Global Safety Head; lead responses to complex technical safety issues.
  • Ensure the quality, compliance, and timely delivery of safety documents (e.g., RMPs, PSURs/PSRs) and safety contributions to study design, protocol concepts, regulatory submissions, HA/EC queries, and labeling for global markets.
  • Provide strategic safety leadership to safety medical directors and scientists, guiding study and program execution, data monitoring and interpretation, signal management, and post‑marketing surveillance to inform labeling and risk minimization.
  • Build and maintain strong internal and external networks, including alliance partners, to drive proactive, cross‑functional, solution‑oriented safety actions; may support due diligence and in‑licensing assessments.
  • Ensuring expert input to safety-relevant elements of study design and interpretation, including efficient use of digital/ artificial intelligence (AI) tools and methodology (e.g. adverse event visualisation and disproportionality analysis).
  • Line manage and develop a team of safety physicians and/or scientists; embed new processes, systems, and ways of working; prioritize risk mitigation and effective issue resolution; operate to the highest ethical, quality, GxP, and AZ standards.

Benefits

  • short-term incentive bonus opportunity
  • equity-based long-term incentive program
  • retirement contribution
  • commission payment eligibility
  • qualified retirement program [401(k) plan]
  • paid vacation and holidays
  • paid leaves
  • health benefits including medical, prescription drug, dental, and vision coverage
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service